The rising popularity of GLP-1 drugs like Ozempic and Wegovy for weight loss has led to a surge in counterfeit versions, posing serious health risks. The FDA warns against purchasing these drugs online due to the prevalence of scams and the potential for dangerous adulterated products. The article highlights the experiences of individuals seeking these medications and emphasizes the importance of consulting with licensed healthcare professionals and pharmacies.
Weight loss is a common New Year's resolution and studies show more people are turning to weight loss drugs, like Ozempic and Wegovy . Both are GLP-1 drugs, which stands for glucagon-like peptide-1, a natural hormone that helps regulate blood sugar, slow down digestion and reduce appetite. But as GLP-1 drugs spike in popularity, the FDA says hazardous counterfeit versions are also on the rise and pose serious risks.
'They looked at my bloodwork to make sure I was going to be able to handle the drug and then I had a FaceTime conversation,' said Miller. 'Anytime I had an issue I would just text the nurse practitioner if I had questions, concerns.'IV Drips CEO Bracha Banayan is also a nurse practitioner who says she took Ozempic after two years of dieting and exercise failed to help her lose pandemic-related weight gain.'My lifestyle changed,' Banayan said.
WEIGHT LOSS COUNTERFEIT DRUGS OZEMPIC WEGOVY GLP-1 FDA HEALTH RISKS ONLINE PHARMACY
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The Rise of Ozempic and Wegovy: Reshaping Fashion and Wellness TrendsFrom weight loss jabs dominating headlines to a surge in second-hand clothing sales, the accessibility of semaglutide-based drugs like Ozempic and Wegovy is causing unexpected shifts in the fashion and wellness industries. This guide explores the impact on luxury retail, size inclusivity, and the beauty sector.
Read more »
Ozempic, Wegovy and other new drugs are selected for Medicare's price negotiationsThe Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers.
Read more »
Medicare to Negotiate Prices for Weight Loss Drugs Ozempic and WegovyThe Biden administration announced that popular weight loss drugs Ozempic and Wegovy will be included in Medicare's price negotiation program. This move is expected to result in billions of dollars in savings for taxpayers, with negotiations handled by the incoming Trump administration.
Read more »
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic and WegovyThe Biden administration has added 15 more drugs to Medicare's list of medications subject to price negotiations, bringing the total to 25. The new additions include popular drugs like Ozempic and Wegovy, with the negotiations expected to generate billions of dollars in savings for taxpayers. The price negotiations will be handled by the incoming Trump administration.
Read more »
Ozempic, Wegovy and other drugs are among 15 selected for Medicare's price negotiationsThe Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers.
Read more »
Ozempic, Wegovy among drugs selected for Medicare's price negotiationsThe move could mean savings for consumers.
Read more »